Zinc Secures £46M for Science Fund

Science-heavy startups often need more patient capital than standard software companies. Zinc’s new fund commitment is a signal that UK public-backed capital is still trying to support deeptech company formation.

What happened

The British Business Bank committed up to £46M to Zinc’s new Science-for-Impact Fund, which is targeting £70M overall.

The fund plans to back early-stage deeptech companies across health, environment, advanced manufacturing, clean energy, life sciences, engineering, biology and AI.

Why it matters

Deeptech startups face a different funding problem from software startups. They often need longer development timelines, technical validation, specialist talent and more capital before revenue becomes visible.

Public-backed commitments can help crowd in private investors, especially in areas where the social or strategic value is high but the path to commercialisation is slower.

The bigger picture

The UK wants more companies built from science, but the bridge from lab to market remains difficult. Funds like Zinc’s are part of that bridge: translating research, founder formation and early capital into investable companies.

The success test will be whether these funds produce durable startups, not just more programmes around innovation.